-
India likely to get Covid-19 vaccine for children by Sept
Covid-19 vaccination for children: Bharat Biotech’s clinical trials for the children’s vaccine has been completed
-
Study on mixing of Covaxin and Covishield doses approved
An expert panel of the CDSCO, on July 29 had recommended granting permission for conducting the study. The trial will involve 300 healthy volunteers.
-
Covishield, Covaxin mixing can give better results: ICMR
A combination of Covishield followed by Covaxin was not only safe but also elicited better immunogenicity according to the ICMR's study.
-
SEC panel approves trial of Covaxin-nasal vaccine mix
Bharat Biotech will be mixing Covaxin, which is administered intramuscularly, with a nasal inoculation based on a different vector.
-
Government plans to boost the supply of Covid-19 vaccines
Covishield supply to increase 12-13 crore doses in a month starting from August; Covaxin supply to go up to 2.5 crore doses a month.
-
Four vaccine candidates for children: All you need to know
Researchers and pharmaceutical companies have already been studying the efficacy of the existing vaccines among the young population
-
Government places an order for 66 crore doses of Covid-19 vaccines
The government aims to procure 96 crore doses of Covid-19 vaccines between August-December.
-
Covaxin to get WHO approval at the earliest
According to WHO, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.
-
Final analysis of Covaxin efficacy out; vaccine 65.2% effective against Delta variant
Bharat Biotech on Saturday said it concluded the final analysis of Covaxin efficacy from Phase-3 trials
-
Bharat Biotech’s Covaxin 65.2% effective against delta variant
The efficacy analysis demonstrates Covaxin to be 93.4% effective against severe symptomatic Covid-19 cases
